FR2812546B1 - 5-CHAIN HETEROCYCLE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS - Google Patents

5-CHAIN HETEROCYCLE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS

Info

Publication number
FR2812546B1
FR2812546B1 FR0010151A FR0010151A FR2812546B1 FR 2812546 B1 FR2812546 B1 FR 2812546B1 FR 0010151 A FR0010151 A FR 0010151A FR 0010151 A FR0010151 A FR 0010151A FR 2812546 B1 FR2812546 B1 FR 2812546B1
Authority
FR
France
Prior art keywords
medicaments
preparation
application
heterocycle derivatives
chain heterocycle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0010151A
Other languages
French (fr)
Other versions
FR2812546A1 (en
Inventor
De Lassauniere Pierre Etienne Chabrier
Jeremiah Harnett
Dennis Bigg
Jacques Pommier
Jacques Lannoy
Anne Marie Liberatore
Christophe Thurieau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority to FR0010151A priority Critical patent/FR2812546B1/en
Priority to TW089121109A priority patent/TWI283577B/en
Priority to TW093132951A priority patent/TWI292316B/en
Priority to EP05076749.0A priority patent/EP1589007B1/en
Priority to AT02076763T priority patent/ATE522213T1/en
Priority to RU2002112227/15A priority patent/RU2271355C2/en
Priority to HU0203841A priority patent/HU228254B1/en
Priority to KR1020027004578A priority patent/KR100731698B1/en
Priority to NZ518304A priority patent/NZ518304A/en
Priority to CNB008158479A priority patent/CN100488506C/en
Priority to IL14889600A priority patent/IL148896A0/en
Priority to RU2005112774/04A priority patent/RU2380362C2/en
Priority to JP2001529718A priority patent/JP4972263B2/en
Priority to MXPA02003665A priority patent/MXPA02003665A/en
Priority to KR1020077013941A priority patent/KR20070068491A/en
Priority to ES05076749.0T priority patent/ES2544856T3/en
Priority to DK05076749.0T priority patent/DK1589007T3/en
Priority to AT00967988T priority patent/ATE338547T1/en
Priority to NZ533429A priority patent/NZ533429A/en
Priority to PT50767490T priority patent/PT1589007E/en
Priority to DK00967988T priority patent/DK1223933T3/en
Priority to DE60030574T priority patent/DE60030574T2/en
Priority to CA2388505A priority patent/CA2388505C/en
Priority to CZ2002-1292A priority patent/CZ304331B6/en
Priority to BR0014649-8A priority patent/BR0014649A/en
Priority to ES00967988T priority patent/ES2270873T3/en
Priority to EP02076763A priority patent/EP1228760B1/en
Priority to PL355147A priority patent/PL215580B1/en
Priority to AU77965/00A priority patent/AU783129B2/en
Priority to MYPI20004725A priority patent/MY145388A/en
Priority to PT00967988T priority patent/PT1223933E/en
Priority to EP00967988A priority patent/EP1223933B1/en
Priority to PCT/FR2000/002805 priority patent/WO2001026656A2/en
Priority to ARP000105353A priority patent/AR029006A1/en
Publication of FR2812546A1 publication Critical patent/FR2812546A1/en
Priority to IL148896A priority patent/IL148896A/en
Priority to NO20021689A priority patent/NO331874B1/en
Priority to HK03101645.4A priority patent/HK1049957B/en
Priority to US10/681,002 priority patent/US20040132788A1/en
Priority to US10/915,001 priority patent/US7291641B2/en
Priority to US10/575,249 priority patent/US20070054900A1/en
Priority to US11/256,901 priority patent/US20070021390A1/en
Priority to CY20061101600T priority patent/CY1106237T1/en
Priority to US11/708,531 priority patent/US20070179153A1/en
Priority to IL185118A priority patent/IL185118A0/en
Priority to US12/001,439 priority patent/US7956075B2/en
Application granted granted Critical
Publication of FR2812546B1 publication Critical patent/FR2812546B1/en
Priority to RU2009136591/04A priority patent/RU2530882C2/en
Priority to US13/053,092 priority patent/US8288560B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/417—Imidazole-alkylamines, e.g. histamine, phentolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/04—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0010151A 1999-10-11 2000-08-01 5-CHAIN HETEROCYCLE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS Expired - Fee Related FR2812546B1 (en)

Priority Applications (47)

Application Number Priority Date Filing Date Title
FR0010151A FR2812546B1 (en) 2000-08-01 2000-08-01 5-CHAIN HETEROCYCLE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS
TW089121109A TWI283577B (en) 1999-10-11 2000-10-09 Pharmaceutical composition of imidazole derivatives acting as modulators of sodium channels and the use thereof
TW093132951A TWI292316B (en) 1999-10-11 2000-10-09 Pharmaceutical composition of thiazole derivatives intended to inhibit mao and/or lipidic peroxidation and/or to act as modulators of sodium channels and the use thereof
EP05076749.0A EP1589007B1 (en) 1999-10-11 2000-10-10 5-membered heterocycle derivatives, production thereof and their use as medicaments
AT02076763T ATE522213T1 (en) 1999-10-11 2000-10-10 FIVE-MEMBED HETERORING DERIVATIVES, THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS
RU2002112227/15A RU2271355C2 (en) 1999-10-11 2000-10-10 Derivatives of five-membered heterocycles, method for their preparing and their using as medicines
HU0203841A HU228254B1 (en) 1999-10-11 2000-10-10 5-membered heteroaromatic compound and pharmaceutical compositions containing it
KR1020027004578A KR100731698B1 (en) 1999-10-11 2000-10-10 5-Membered Heterocycle Derivatives, Production Thereof and Use Thereof as Medicaments
NZ518304A NZ518304A (en) 1999-10-11 2000-10-10 5-membered heterocycle derivatives, their production and use to inhibit monoamine oxydases (MAO) and/or lipidic peroxidation and/or to act as modulators of the sodium channels
CNB008158479A CN100488506C (en) 1999-10-11 2000-10-10 5-membered heterocycle derivatives, production thereof and use as medicaments
IL14889600A IL148896A0 (en) 1999-10-11 2000-10-10 5-membered heterocycle derivatives, production thereof and use thereof as medicaments
RU2005112774/04A RU2380362C2 (en) 1999-10-11 2000-10-10 Derivatives of five-member heterocycles, method of production and use thereof as medicinal agents
JP2001529718A JP4972263B2 (en) 1999-10-11 2000-10-10 5-membered heterocyclic derivative, its production method and its use as a medicament
MXPA02003665A MXPA02003665A (en) 1999-10-11 2000-10-10 5-membered heterocycle derivatives and use thereof as monoamine oxidase inhibitors.
KR1020077013941A KR20070068491A (en) 1999-10-11 2000-10-10 5-membered heterocycle derivatives, production thereof and use thereof as medicaments
ES05076749.0T ES2544856T3 (en) 1999-10-11 2000-10-10 Derivatives of 5-member heterocycles, their preparation and their application as medicines
DK05076749.0T DK1589007T3 (en) 1999-10-11 2000-10-10 5-link heterocycle derivatives, their preparation and use as pharmaceuticals
AT00967988T ATE338547T1 (en) 1999-10-11 2000-10-10 FIVE-MEMBER DERIVATIVES OF HETEROCYCLES AND THEIR USE AS MONOAMIN OXIDASE INHIBITORS
NZ533429A NZ533429A (en) 1999-10-11 2000-10-10 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
PT50767490T PT1589007E (en) 1999-10-11 2000-10-10 5-membered heterocycle derivatives, production thereof and their use as medicaments
DK00967988T DK1223933T3 (en) 1999-10-11 2000-10-10 5-membered derivatives of heterocycles and their use as monoamine oxidase inhibitors
DE60030574T DE60030574T2 (en) 1999-10-11 2000-10-10 FIVE-LID DERIVATIVES OF HETEROCYCLES AND THEIR USE AS MONOAMINOXIDASE INHIBITORS
CA2388505A CA2388505C (en) 1999-10-11 2000-10-10 5-membered heterocycle derivatives, their preparation and application as medicine
CZ2002-1292A CZ304331B6 (en) 1999-10-11 2000-10-10 Use of thiazole derivatives for the preparation of a medicament
BR0014649-8A BR0014649A (en) 1999-10-11 2000-10-10 Use of a product, medicine, compound and pharmaceutical composition
ES00967988T ES2270873T3 (en) 1999-10-11 2000-10-10 DERIVATIVES OF 5-MEMBER HETEROCICLES AND ITS APPLICATION AS INHIBITORS OF MONOAMINE OXIDASA.
EP02076763A EP1228760B1 (en) 1999-10-11 2000-10-10 5-membered heterocycle derivatives, production thereof and use thereof as medicaments
PL355147A PL215580B1 (en) 1999-10-11 2000-10-10 5-membered heterocycle derivatives and use thereof as monoamine oxidase inhibitors
AU77965/00A AU783129B2 (en) 1999-10-11 2000-10-10 5-membered heterocycle derivatives, production thereof and use thereof as medicaments
MYPI20004725A MY145388A (en) 1999-10-11 2000-10-10 5-membered heterocycle derivatives, production thereof and sue thereof as medicaments
PT00967988T PT1223933E (en) 1999-10-11 2000-10-10 5-membered heterocycle derivatives and use thereof as monoaminoxidase inhibitors
EP00967988A EP1223933B1 (en) 1999-10-11 2000-10-10 5-membered heterocycle derivatives and use thereof as monoaminoxidase inhibitors
PCT/FR2000/002805 WO2001026656A2 (en) 1999-10-11 2000-10-10 5-membered heterocycle derivatives and use thereof as monoamine oxidase inhibitors
ARP000105353A AR029006A1 (en) 1999-10-11 2000-10-11 DERIVATIVES OF HETEROCICLOS WITH 5 MEMBERS, THEIR PREPARATION AND THEIR USE AS MEDICATIONS
IL148896A IL148896A (en) 1999-10-11 2002-03-26 Use of thiazole derivatives for preparing medicaments, pharmaceutical compositions comprising them and such a novel compound
NO20021689A NO331874B1 (en) 1999-10-11 2002-04-10 4- [2 (aminomethyl) -1,3-thiazol-4-yl] -2,6-di (tert-butyl) phenol, use as a medicament, and use in the treatment of disease.
HK03101645.4A HK1049957B (en) 1999-10-11 2003-03-06 5-membered heterocycle derivatives, production thereof and use thereof as medicaments
US10/681,002 US20040132788A1 (en) 1999-10-11 2003-10-08 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
US10/915,001 US7291641B2 (en) 1999-10-11 2004-08-10 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
US10/575,249 US20070054900A1 (en) 1999-10-11 2004-10-08 4-Phenlthiazole and 4-phenylimidizole derivatives and their use as medicaments for the treatment of neurodegenerative diseases, pain and epilepsy
US11/256,901 US20070021390A1 (en) 1999-10-11 2005-10-24 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
CY20061101600T CY1106237T1 (en) 1999-10-11 2006-11-08 ETEOCYCLIC DERIVATIVES WITH 5 MEMBERED RING AND THEIR APPLICATION AS INHIBITORS OF MONOAMINO OXIDATION
US11/708,531 US20070179153A1 (en) 1999-10-11 2007-02-20 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
IL185118A IL185118A0 (en) 1999-10-11 2007-08-08 5-membered heterocycle derivatives,production thereof and use thereof as medicaments
US12/001,439 US7956075B2 (en) 1999-10-11 2007-12-11 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
RU2009136591/04A RU2530882C2 (en) 1999-10-11 2009-10-02 Five-merous heterocycle derivatives, method for preparing and using them as therapeutic agents
US13/053,092 US8288560B2 (en) 1999-10-11 2011-03-21 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0010151A FR2812546B1 (en) 2000-08-01 2000-08-01 5-CHAIN HETEROCYCLE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS

Publications (2)

Publication Number Publication Date
FR2812546A1 FR2812546A1 (en) 2002-02-08
FR2812546B1 true FR2812546B1 (en) 2008-11-21

Family

ID=8853199

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0010151A Expired - Fee Related FR2812546B1 (en) 1999-10-11 2000-08-01 5-CHAIN HETEROCYCLE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS

Country Status (1)

Country Link
FR (1) FR2812546B1 (en)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3941438A1 (en) * 1989-12-15 1991-06-20 Hoechst Ag NEW 2-SUBSTITUTED 4- (3-ALKYL-5-TERT.-BUTYL-4-HYDROXY-PHENYL) -THIAZOLE, PROCESS FOR THEIR MANUFACTURE, THE MEDICAMENT CONTAINING THEIR AND ITS USE
JP2941950B2 (en) * 1994-11-23 1999-08-30 ニューロゲン コーポレイション Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives; a novel class of dopamine receptor subtype specific ligands
WO1998015274A1 (en) * 1996-10-07 1998-04-16 Eli Lilly And Company Novel compounds useful as neuro-protective agents
WO1998027108A2 (en) * 1996-12-16 1998-06-25 Fujisawa Pharmaceutical Co., Ltd. New amide compounds and their use as nitric oxide synthase inhibitors
FR2764889B1 (en) * 1997-06-20 2000-09-01 Sod Conseils Rech Applic NOVEL 2- (IMINOMETHYL) AMINO-PHENYL DERIVATIVES, THEIR PREPARATION, THEIR USE AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EP0908180A3 (en) * 1997-08-28 1999-04-21 Eli Lilly And Company Use of phenyl oxazole or phenyl thiazole derivatives for treating pain
CA2335339A1 (en) * 1998-06-12 1999-12-16 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R .beta.-carboline compounds
DE69921124T2 (en) * 1998-06-12 2005-11-10 Société de Conseils de Recherches et d'Applications Scientifiques S.A.S. Imidazole derivatives and their use as a somatostatin receptor
AU2717100A (en) * 1998-12-31 2000-07-31 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Prenyl transferase inhibitors

Also Published As

Publication number Publication date
FR2812546A1 (en) 2002-02-08

Similar Documents

Publication Publication Date Title
FR2791678B1 (en) 1,4-DIAZABICYCLO [3.2.2] NONANE-4-CARBOXYLATES AND -CARBOXAMIDES DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
PT1589007E (en) 5-membered heterocycle derivatives, production thereof and their use as medicaments
PT1296974E (en) 2-cyanopyrrolidine derivatives and their use as medicaments
MA26816A1 (en) AMINO-TRIAZOLOPYRIDINE DERIVATIVES
FR2790474B1 (en) PYRIDOPYRANOAZEPINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2806720B1 (en) 2,2,6,6-DIETHYL-DIMETHYL-1-ALCOXYPIPERIDINE DERIVATIVES AND CORRESPONDING 1-OXIDES
FR14C0044I2 (en) 3-(2-OXO-1,3']BIPYRROLIDINYL-3-YLIDENEMETHYL)-CEPHEMES DERIVATIVES
FR2809731B1 (en) 1,4-DIAZABICYCLO- [3.2.2] NONANE-PHEYLISOXAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
NO20022021D0 (en) Indeno-, naphtho- and benzocyclohepta-dihydrotiazole derivatives, the preparation of the same and their use as anorexic drugs
FR2850377B1 (en) ARYLALKYLCARBAMATE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2809730B1 (en) 1,4-DIAZABICYCLO [3.2.2] NONANEBENZOXAZOLE, -BENZOTHIAZOLE AND -BENZIMIDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2804430B1 (en) 4-HETEROARYL-1,4-DIAZABICYCLO [3.2.2] NONANE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
EE200100422A (en) Epothilone derivatives, process for their preparation and pharmaceutical use
FR2792318B1 (en) INDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2845388B1 (en) 1,4-DIAZABICYCLO [3.2.2] NONANECARBOXAMIDES DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
HUP0201810A2 (en) Sootepenseone and its derivatives, their preparation and use as medicament
FR2799461B1 (en) 5-CHAIN CHAIN HETEROCYCLE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS
NO20014692D0 (en) 3-amidinobenzenesulfonamide derivatives, medical compositions containing them and intermediates in the preparation thereof
FR2842527B1 (en) ACYLOXYPYROLIDINE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE THEREOF
ITMI20001848A0 (en) DRUGS FOR INCONTINENCE.
FR2812546B1 (en) 5-CHAIN HETEROCYCLE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS
FR2792635B1 (en) CYCLOBUTENE-3,4-DIONE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2823208B1 (en) 5-CHAIN CHAIN HETEROCYCLE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS
FR2839974B1 (en) PHENYL-FURANE OR PHENYL-THIOPHENE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MEDICAMENTS
FR2805815B1 (en) POLYFLUOROALKYLIMIDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Legal Events

Date Code Title Description
CA Change of address
CD Change of name or company name
PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19

ST Notification of lapse

Effective date: 20200405